Health and Life Sciences news
As the nation prepares for a flu season amid the global COVID-19 pandemic, several myths and misconceptions about the flu vaccine will reappear.
There are many unknowns with the COVID-19 pandemic, but people’s relationship with alcohol and rationale for drinking seem to be consistent.
Each year, more than 50 million Americans develop gastrointestinal issues that lead them to question the safety of their most recent meals. It’s entirely possible that their distress could be caused not by the food they have eaten, but the meals served to their furry friends.
A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer’s disease neurodegeneration.
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
Purdue University innovators are working on inventions to use micro-chip technology in implantable devices and other wearable products such as smart watches to improve biomedical devices, including those used to monitor people with glaucoma and heart disease.
Researchers at Purdue University have developed a treatment to infuse a hardened metal surface with naturally occurring antimicrobial peptides.